On 4 JUNE Northwest Biotherapeutics, Inc (NASDAQ:NWBO) announced that Linda F. Powers, CEO, will present at the Jefferies 2014 Global Healthcare Conference, which is being held in New York. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) weekly performance is 9.20%. On last trading day company shares ended up $6.41. Analysts mean target price for the company is $10.05. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) distance from 50-day simple moving average (SMA50) is 5.51%.
On 9 JUNE CytRx Corporation (NASDAQ:CYTR) announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS). CytRx Corporation (NASDAQ:CYTR) shares advanced 5.91% in last trading session and ended the day on $5.02. CYTR return on assets is -68.30%. CytRx Corporation (NASDAQ:CYTR) quarterly performance is 5.02%.
Albany Molecular Research, Inc. (NASDAQ:AMRI) reported $0.16 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.23 by $0.07. The company had revenue of $51.00 million for the quarter, compared to the consensus estimate of $62.19 million. On average, analysts predict that Albany Molecular Research will post $0.82 earnings per share for the current fiscal year. Albany Molecular Research, Inc. (NASDAQ:AMRI) shares moved up 7.05% in last trading session and was closed at $18.67, while trading in range of $17.69 – $18.76. Albany Molecular Research, Inc. (NASDAQ:AMRI) year to date (YTD) performance is 85.22%.
Pacific Biosciences of California (NASDAQ:PACB) ended the last trading day at $5.36. Company weekly volatility is calculated as 5.88% and price to cash ratio as 3.42. Pacific Biosciences of California (NASDAQ:PACB) showed a positive weekly performance of 13.83%.
Alder Biopharmaceuticals Inc (NASDAQ:ALDR) announced that members of Alder’s senior management team will present at two upcoming conferences in June: Wells Fargo Securities 2014 Healthcare Conference Date: Tuesday, June 17, 2014 Time: 4:40 p.m. EDT. Washington Biotechnology & Biomedical Association (WBBA) 14th Annual Life Science Innovation Northwest Date: Thursday, June 19, 2014 Time: 1:45 p.m. PDT. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) weekly performance is 25.22%. On last trading day company shares ended up $17.43. Analysts mean target price for the company is $23.00. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) distance from 50-day simple moving average (SMA50) is 52.46%.